Gender |
|
|
Male |
0% |
0/7 |
Female |
57.1% |
4/7 |
Indifferent |
42.9% |
3/7 |
Unknown |
0% |
0/7 |
General |
|
|
Birth Length abnormalities |
28.6% |
2/7 |
< P3 : Birth length less than 3rd percentile |
28.6% |
2/7 |
Birth Weight abnormalities |
28.6% |
2/7 |
< P3 : Small for gestational age |
28.6% |
2/7 |
Birth Head circumference abnormalities |
42.9% |
3/7 |
< P3 : Congenital microcephaly |
42.9% |
3/7 |
Current Height abnormalities |
42.9% |
3/7 |
< P3 : Short stature |
42.9% |
3/7 |
Current Weight abnormalities |
14.3% |
1/7 |
< P3 : Decreased body weight |
14.3% |
1/7 |
Current Head circumference abnormalities |
100.0% |
7/7 |
< P3 : Microcephaly |
100.0% |
7/7 |
Neurology |
|
|
Neurological abnormalities |
71.4% |
5/7 |
Hyperkinesis |
57.1% |
4/7 |
Dysarthria |
14.3% |
1/7 |
Focal seizures |
14.3% |
1/7 |
Generalized tonic-clonic seizures |
14.3% |
1/7 |
Microcephaly |
14.3% |
1/7 |
Muscular hypotonia |
14.3% |
1/7 |
Myotonia |
14.3% |
1/7 |
Brain abnormality |
83.3% |
5/6 |
Cerebellar vermis hypoplasia |
50.0% |
3/6 |
Abnormality of the corpus callosum |
16.7% |
1/6 |
Abnormality of the fourth ventricle |
16.7% |
1/6 |
Cerebellar gliosis |
16.7% |
1/6 |
Cortical gyral simplification |
16.7% |
1/6 |
Enlarged cisterna magna |
16.7% |
1/6 |
Transient ischemic attack |
16.7% |
1/6 |
Facial abnormalities |
|
|
Abnormality of the ear |
14.3% |
1/7 |
Protruding ear |
14.3% |
1/7 |
Abnormality of the eye |
85.7% |
6/7 |
Upslanted palpebral fissure |
57.1% |
4/7 |
Anisocoria |
14.3% |
1/7 |
Hypoplasia of the iris |
14.3% |
1/7 |
Microphthalmia |
14.3% |
1/7 |
Optic nerve coloboma |
14.3% |
1/7 |
Optic atrophy |
14.3% |
1/7 |
Palpebral edema |
14.3% |
1/7 |
Abnormality of the nose |
28.6% |
2/7 |
Bulbous nose |
14.3% |
1/7 |
Long philtrum |
14.3% |
1/7 |
Short columella |
14.3% |
1/7 |
Abnormality of the mouth |
28.6% |
2/7 |
Mandibular prognathia |
14.3% |
1/7 |
Midface retrusion |
14.3% |
1/7 |
Misalignment of teeth |
14.3% |
1/7 |
Wide mouth |
14.3% |
1/7 |
Visual and hearing impairments |
|
|
Abnormal vision |
50.0% |
3/6 |
Microphthalmia |
16.7% |
1/6 |
Myopia |
16.7% |
1/6 |
Retinal pigment epithelial atrophy |
16.7% |
1/6 |
Urogenital |
|
|
Abnormality of the urogenital system |
57.1% |
4/7 |
Gonadal dysgenesis |
42.9% |
3/7 |
Sex reversal |
42.9% |
3/7 |
Abnormal external genitalia |
28.6% |
2/7 |
Abnormality of the urethra |
14.3% |
1/7 |
Abnormality of the epididymis |
14.3% |
1/7 |
Aplasia of the uterus |
14.3% |
1/7 |
Aplasia of the ovary |
14.3% |
1/7 |
Hypoplastic labia minora |
14.3% |
1/7 |
Hypoplastic labia majora |
14.3% |
1/7 |
Microphallus |
14.3% |
1/7 |
Primary amenorrhea |
14.3% |
1/7 |
Testicular dysgenesis |
14.3% |
1/7 |
Skeleton |
|
|
Skeletal abnormalities |
85.7% |
6/7 |
Brachydactyly syndrome |
57.1% |
4/7 |
Narrow iliac wings |
57.1% |
4/7 |
Enlarged epiphyses |
42.9% |
3/7 |
Bell-shaped thorax |
28.6% |
2/7 |
Enlarged metaphyses |
28.6% |
2/7 |
Nail dysplasia |
28.6% |
2/7 |
Short distal phalanx of finger |
28.6% |
2/7 |
Thin clavicles |
28.6% |
2/7 |
Trapezoidal shaped vertebral bodies |
28.6% |
2/7 |
Abnormality of the femoral neck |
14.3% |
1/7 |
Abnormality of skeletal maturation |
14.3% |
1/7 |
Abnormality of the metaphyses |
14.3% |
1/7 |
Abnormality of the vertebrae |
14.3% |
1/7 |
Broad metatarsal |
14.3% |
1/7 |
Capitate-hamate fusion |
14.3% |
1/7 |
Clinodactyly of the 5th finger |
14.3% |
1/7 |
Distal widening of metacarpals |
14.3% |
1/7 |
Joint laxity |
14.3% |
1/7 |
Micromelia |
14.3% |
1/7 |
Scoliosis |
14.3% |
1/7 |
Severe short stature |
14.3% |
1/7 |
Short long bone |
14.3% |
1/7 |
Short phalanx of finger |
14.3% |
1/7 |
Short ribs |
14.3% |
1/7 |
Spinal rigidity |
14.3% |
1/7 |
Spondylolisthesis at L5-S1 |
14.3% |
1/7 |
Thin long bone diaphyses |
14.3% |
1/7 |
Thin ribs |
14.3% |
1/7 |
Type A brachydactyly |
14.3% |
1/7 |
Skin / Hair / Nails |
|
|
Abnormality of the skin/hair/nails |
28.6% |
2/7 |
Hirsutism |
14.3% |
1/7 |
Multiple cafe-au-lait spots |
14.3% |
1/7 |
Endocrine / Immunological / Metabolic |
|
|
Abnormality of the endocrine system |
42.9% |
3/7 |
Decreased serum testosterone level |
14.3% |
1/7 |
Hypergonadotropic hypogonadism |
14.3% |
1/7 |
Increased serum testosterone level |
14.3% |
1/7 |
Abnormality of the metabolic system |
57.1% |
4/7 |
Elevated serum creatine phosphokinase |
57.1% |
4/7 |
Hypercholesterolemia |
14.3% |
1/7 |
Neoplasia |
|
|
Neoplasia |
14.3% |
1/7 |
Testicular seminoma |
14.3% |
1/7 |